A FAST AND EASY EYEBALL METHOD TO CLASSIFY LUMINAL-TYPE BREAST CANCERS: NO MORE NEED TO COUNT KI67!

被引：0
|
作者：
Hida, A. I. [1 ]
Oshiro, Y. [1 ]
Kawaguchi, H. [1 ]
Inoue, H. [1 ]
Moriya, T. [2 ]
机构：
[1] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan
[2] Kawasaki Med Sch, Kurashiki, Okayama, Japan
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 22 条
  • [11] Luminal-Type Breast Cancer: Correlation of Apparent Diffusion Coefficients with the Ki-67 Labeling Index
    Mori, Naoko
    Ota, Hideki
    Mugikura, Shunji
    Takasawa, Chiaki
    Ishida, Takanori
    Watanabe, Gou
    Tada, Hiroshi
    Watanabe, Mika
    Takase, Kei
    Takahashi, Shoki
    RADIOLOGY, 2015, 274 (01) : 66 - 73
  • [12] Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results
    Noske, Aurelia
    Anders, Sophie-Isabelle
    Ettl, Johannes
    Hapfelmeier, Alexander
    Steiger, Katja
    Specht, Katja
    Weichert, Wilko
    Kiechle, Marion
    Klein, Evelyn
    BREAST, 2020, 49 : 101 - 107
  • [13] Correlation between a Manual Count and an Automated System of Estimation of Ki67 in Breast Cancers in Danbury Hospital
    Odujoko, Oluwole
    Sandeep, Fnu
    Olayinka, Oluwaseyi
    Vidhun, Ramapriya
    Barasch, Samuel
    LABORATORY INVESTIGATION, 2023, 103 (03) : S193 - S193
  • [14] High reproducibility in Ki67 assessment in luminal breast cancers enabled by French recommendations and digital image analysis
    Beniere, C.
    Rouzier, R.
    Bellocq, J. -P.
    Allory, Y.
    Guinebretiere, J. -M.
    VIRCHOWS ARCHIV, 2018, 473 : S30 - S31
  • [15] A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
    Kobayashi, Takayuki
    Iwaya, Keiichi
    Moriya, Tomoyuki
    Yamasaki, Tamio
    Tsuda, Hitoshi
    Yamamoto, Junji
    Matsubara, Osamu
    BMC CLINICAL PATHOLOGY, 2013, 13
  • [16] Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
    Tan, Shirong
    Fu, Xin
    Xu, Shouping
    Qiu, Pengfei
    Lv, Zhidong
    Xu, Yingying
    Zhang, Qiang
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [17] Ki67 assessment using a 5-grade scale revealed high reproducibility for luminal type breast cancer
    Aogi, K.
    Hida, A.
    Oshiro, Y.
    Inoue, H.
    Kawaguchi, H.
    Yamashita, N.
    Moriya, T.
    BREAST, 2015, 24 : S39 - S39
  • [18] Ki67 Heterogeneity in Estrogen Receptor-Positive Breast Cancers: Which Tumor Type Has the Most Heterogeneity?
    Himuro, Takanori
    Horimoto, Yoshiya
    Arakawa, Atsushi
    Tanabe, Masahiko
    Saito, Mitsue
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2016, 24 (02) : 103 - 107
  • [19] Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
    Hida, Akira I.
    Bando, Kenji
    Sugita, Atsuro
    Maeda, Toshiharu
    Ueda, Norifumi
    Matsukage, Shoichi
    Nakanishi, Mamoru
    Kito, Katsumi
    Miyazaki, Tatsuhiko
    Ohtsuki, Yuji
    Oshiro, Yumi
    Inoue, Hiromichi
    Kawaguchi, Hidetoshi
    Yamashita, Natsumi
    Aogi, Kenjiro
    Moriya, Takuya
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (05) : 356 - 361
  • [20] Association Between Shear Wave Elastography of Virtual Touch Tissue Imaging Quantification Parameters and the Ki-67 Proliferation Status in Luminal-Type Breast Cancer
    Liu, Yubo
    Huang, Yini
    Han, Jing
    Wang, Jianwei
    Li, Fei
    Zhou, Jianhua
    JOURNAL OF ULTRASOUND IN MEDICINE, 2019, 38 (01) : 73 - 80
123